Tau, a key protein in AD and FTD, is a PD GWAS locus and has been observed in approximately 50% of PD patients post-mortem, illustrating the relevance of functional study of LRRK2 for further mechanistic insights potentially applicable to a range of neurodegenerative conditions. The gene discussed is MAPT; the disease is Alzheimer disease.